Skip to main content
Equibles
IDXX logo

IDXX · Idexx Laboratories Inc /De · Metrics

Track IDXX — free

Use IDXX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IDXX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$557.93 +2.13 (+0.38%) At close · Oct 20
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$43.95B
Shares
78.78M
Volume · Oct 20 439.98K Avg daily vol (3M) 546.35K

IDXX metrics

114 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$557.93
Market cap
$43.95B

Price action

20 metrics
Price change (1W)
+7.2%
Price change (30D)
+8.3%
Price change (3M)
+1.0%
Price change (6M)
-1.9%
Price change (YTD)
-17.5%
Price change (1Y)
-13.3%
Trailing year
Price change (5Y)
-13.1%
52-week high
$766.68
52-week low
$504.70
Change from 52-week high
-27.2%
Change from 52-week low
+10.5%
Annualized volatility
32.2%
Annualized volatility (3M)
25.4%
Beta
0.8
RSI (14D)
63.9
Price vs SMA 50
+4.5%
Price vs SMA 200
-3.6%
Avg volume (3M)
546,348
Relative volume
0.8
Average dollar volume
$297.23M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
78.78M

Valuation

12 metrics
P / E (TTM)
39.2
Trailing earnings · reciprocal yield 2.6%
PEG ratio
2.2
EV / revenue
9.7×
reciprocal yield 10.3%
EV / EBITDA
27.3×
reciprocal yield 3.7%
EV / EBIT
30.2×
reciprocal yield 3.3%
P / sales
9.6×
reciprocal yield 10.4%
P / book
27.2
reciprocal yield 3.7%
FCF yield
2.9%
TTM · current market cap
Buyback yield
2.7%
P / FCF
34.9
reciprocal yield 2.9%
P / operating cash flow
31.9
reciprocal yield 3.1%
Earnings yield
2.6%

Historical valuation

8 metrics
P / E historical average (3Y)
46.7×
reciprocal yield 2.1%
P / E historical average (5Y)
50.8×
reciprocal yield 2.0%
EV / revenue historical average (3Y)
10.9×
reciprocal yield 9.2%
EV / revenue historical average (5Y)
11.5×
reciprocal yield 8.7%
EV / EBIT historical average (3Y)
35.9×
reciprocal yield 2.8%
EV / EBIT historical average (5Y)
39.2×
reciprocal yield 2.5%
EV / EBITDA historical average (3Y)
31.8×
reciprocal yield 3.1%
EV / EBITDA historical average (5Y)
34.6×
reciprocal yield 2.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
2.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-02
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
62.4%
Operating margin
32.0%
Trailing 12 months
Net margin
25.0%
Gross profit (TTM)
$2.84B
Operating profit (TTM)
$1.46B
Net income (TTM)
$1.14B
Trailing 12 months
Diluted EPS (TTM)
$14.23
FCF margin
27.5%
Effective tax rate
20.0%

Per share

11 metrics
Revenue per diluted share (TTM)
$56.81
Gross profit per diluted share (TTM)
$35.48
Operating profit per diluted share (TTM)
$18.21
EBITDA per diluted share (TTM)
$20.13
Net income per diluted share (TTM)
$14.23
Operating cash flow per diluted share (TTM)
$17.10
Free cash flow per diluted share (TTM)
$15.64
Capital expenditures per diluted share (TTM)
$1.46
R&D per diluted share (TTM)
$3.26
Stock compensation per diluted share (TTM)
$0.79
Book value per share
$20.14

Growth

11 metrics
Revenue growth YoY
+9.7%
Year over year
Net income growth YoY
+15.1%
Revenue (TTM)
$4.55B
Trailing 12 months
EPS growth YoY
+17.6%
Shares change YoY
-2.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+8.5%
Revenue CAGR (5Y)
+9.7%
EPS CAGR (3Y)
+17.7%
EPS CAGR (5Y)
+14.3%
FCF CAGR (3Y)
+38.9%
FCF CAGR (5Y)
+14.3%

Quality

14 metrics
Return on equity
70.7%
Return on assets
33.1%
Debt / equity
0.3
Current ratio
1.2
EBITDA (TTM)
$1.61B
Free cash flow (TTM)
$1.25B
Quick ratio
0.9
Interest coverage
38.6
Net debt / EBITDA
0.2
Return on invested capital
62.6%
Trailing 12 months
Net cash
−$252.93M
Latest balance sheet
Cash & equivalents
$196.93M
Total assets
$3.44B
Total debt
$449.86M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.37B
Capital expenditures (TTM)
$117.18M
R&D (TTM)
$261.46M
SG&A (TTM)
—
Stock compensation (TTM)
$62.97M
R&D / revenue
5.7%
Stock compensation / revenue
1.4%

Ownership (13F)

9 metrics
13F filers
1,309
13F filer change QoQ
-11
Institutional ownership
94.5%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
17.1%
Private-fund adviser ownership
16.4%
Active holders' share change QoQ
+6.7%
Holder tenure
17.6
Price vs estimated holder cost
-3.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.2%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.17M
Insider-sentiment score
44 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 874716 CUSIP 45168D104 13F (30d) 227 filings 222 filers Visit website Investor relations